http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101277710-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06 |
| filingDate | 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101277710-B1 |
| titleOfInvention | Novel atemisinin or dioxoatemiscinin-glycolipid complex derivatives and their use for angiogenesis |
| abstract | The present invention relates to novel dioxoatemicinin-glycolipid complex derivatives and their use for angiogenesis. The dioxoatemicinine-glycolipid complex derivative of the present invention is not only a novel substance per se, but also is safe for human body because it has an antiangiogenic activity more than twice as strong as existing drugs and does not have cytotoxicity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111494457-A |
| priorityDate | 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.